Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: A cross-sectional analysis is a research paper published in PLoS Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes of Health Research
Grant: PJT-153045
National Institute on Aging
Grant: U54AG063546
Canadian Institutes of Health Research
Grant: CIHR fellowship
National Institutes of Health
Grant: 3U54AG063546-02S6
NIA AD/ADRD Health Care Systems Research Collaboratory
Canadian Institutes of Health Research
Grant: unidentified
unidentified
FWCI
6.26
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
Additional file 1 of Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
Additional file 2 of Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
Additional file 2 of Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
Additional file 1 of How do we know a treatment is good enough? A survey of non-inferiority trials
Additional file 1 of How do we know a treatment is good enough? A survey of non-inferiority trials